Premier Anti-Aging Co., Ltd.
Premier Anti-Aging Co., Ltd. Fundamental Analysis
Premier Anti-Aging Co., Ltd. (4934.T) shows weak financial fundamentals with a PE ratio of 15.96, profit margin of 2.24%, and ROE of 4.86%. The company generates $15.0B in annual revenue with weak year-over-year growth of -20.62%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 14.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 4934.T's fundamental strength across five key dimensions:
Efficiency Score
Weak4934.T struggles to generate sufficient returns from assets.
Valuation Score
Excellent4934.T trades at attractive valuation levels.
Growth Score
Weak4934.T faces weak or negative growth trends.
Financial Health Score
Excellent4934.T maintains a strong and stable balance sheet.
Profitability Score
Weak4934.T struggles to sustain strong margins.
Key Financial Metrics
Is 4934.T Expensive or Cheap?
P/E Ratio
4934.T trades at 15.96 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 4934.T's PEG of -0.57 indicates potential undervaluation.
Price to Book
The market values Premier Anti-Aging Co., Ltd. at 0.76 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 16.30 times EBITDA. This signals the market has high growth expectations.
How Well Does 4934.T Make Money?
Net Profit Margin
For every $100 in sales, Premier Anti-Aging Co., Ltd. keeps $2.24 as profit after all expenses.
Operating Margin
Core operations generate 1.78 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $4.86 in profit for every $100 of shareholder equity.
ROA
Premier Anti-Aging Co., Ltd. generates $3.19 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Premier Anti-Aging Co., Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Premier Anti-Aging Co., Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
4934.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
15.96
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.57
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.76
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.36
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.19
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.83
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.05
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How 4934.T Stacks Against Its Sector Peers
| Metric | 4934.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 15.96 | 22.36 | Better (Cheaper) |
| ROE | 4.86% | 1238.00% | Weak |
| Net Margin | 2.24% | -5096.00% (disorted) | Weak |
| Debt/Equity | 0.19 | 1.23 | Strong (Low Leverage) |
| Current Ratio | 2.83 | 2.47 | Strong Liquidity |
| ROA | 3.19% | -191998.00% (disorted) | Weak |
4934.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Premier Anti-Aging Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-21.38%
Industry Style: Defensive, Dividend, Low Volatility
DecliningEPS CAGR
-58.91%
Industry Style: Defensive, Dividend, Low Volatility
DecliningFCF CAGR
334.18%
Industry Style: Defensive, Dividend, Low Volatility
High Growth